|
Volumn 27, Issue 4, 2008, Pages 568-583
|
Randomized phase II trials with a prospective control
|
Author keywords
Balanced allocation; Futility; Minimax design; Multi arm trial; Optimal design; Two stage design
|
Indexed keywords
LENALIDOMIDE;
RITUXIMAB;
ANALYTICAL ERROR;
ARTICLE;
BINOMIAL DISTRIBUTION;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG RESEARCH;
HODGKIN DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MATHEMATICAL COMPUTING;
MONOTHERAPY;
NULL HYPOTHESIS;
PHASE 2 CLINICAL TRIAL;
POWER ANALYSIS;
PROBABILITY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
STEM CELL TRANSPLANTATION;
BIAS (EPIDEMIOLOGY);
HUMANS;
MEDICAL FUTILITY;
MODELS, STATISTICAL;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
|
EID: 39449091622
PISSN: 02776715
EISSN: 10970258
Source Type: Journal
DOI: 10.1002/sim.2961 Document Type: Article |
Times cited : (53)
|
References (12)
|